Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEPN
3051
Septerna Inc
SEPN
$2.08B
| $9.27M | ﹤0.01% |
+404,882
| New | +$9.57M |
|
3052
ICICI Bank
IBN
$107B
| $9.26M | ﹤0.01% |
309,985
+208,732
| +206% | +$6.3M |
|
3053
CALL
T-REX 2X Long Tesla Daily Target ETF
TSLT
$161M
| $9.25M | ﹤0.01% |
244,200
+164,200
| +205% | +$4.45M |
|
3054
PUT
Virtu Financial
VIRT
$5.3B
| $9.22M | ﹤0.01% |
258,400
-4,800
| -2% | -$165K |
|
3055
Gulfport Energy Corp
GPOR
$3.01B
| $9.22M | ﹤0.01% |
+50,041
| New | +$8.03M |
|
3056
East-West Bancorp
EWBC
$18.7B
| $9.21M | ﹤0.01% |
96,153
+46,472
| +94% | +$4.56M |
|
3057
Sabra Healthcare REIT
SBRA
$5.19B
| $9.2M | ﹤0.01% |
531,419
-94,479
| -15% | -$1.73M |
|
3058
Dianthus Therapeutics
DNTH
$6.49B
| $9.2M | ﹤0.01% |
422,038
+362,737
| +612% | +$9.33M |
|
3059
Axcelis
ACLS
$4.33B
| $9.19M | ﹤0.01% |
131,564
+52,420
| +66% | +$4.35M |
|
3060
CALL
OneMain Financial
OMF
$7.56B
| $9.19M | ﹤0.01% |
176,300
-58,900
| -25% | -$3.05M |
|
3061
CALL
Jefferies Financial Group
JEF
$12.7B
| $9.16M | ﹤0.01% |
116,900
-215,400
| -65% | -$15.5M |
|
3062
GigaCloud Technology
GCT
$1.85B
| $9.16M | ﹤0.01% |
494,851
+126,754
| +34% | +$2.93M |
|
3063
Quaker Houghton
KWR
$2.94B
| $9.16M | ﹤0.01% |
65,100
+35,300
| +118% | +$5.57M |
|
|
3064
OneMain Financial
OMF
$7.56B
| $9.16M | ﹤0.01% |
175,637
-39,964
| -19% | -$2.07M |
|
3065
PUT
Aramark
ARMK
$16.4B
| $9.16M | ﹤0.01% |
245,400
-35,200
| -13% | -$1.37M |
|
3066
CALL
Aecom
ACM
$8.12B
| $9.15M | ﹤0.01% |
85,700
+16,000
| +23% | +$1.75M |
|
3067
Camtek
CAMT
$7.72B
| $9.15M | ﹤0.01% |
113,292
-151,618
| -57% | -$11.9M |
|
3068
PUT
Atkore
ATKR
$3.17B
| $9.14M | ﹤0.01% |
109,500
+300
| +0.3% | +$26.4K |
|
3069
Magnolia Oil & Gas
MGY
$6.22B
| $9.13M | ﹤0.01% |
390,571
-257,669
| -40% | -$6.69M |
|
3070
CALL
Campbell Soup
CPB
$6.91B
| $9.13M | ﹤0.01% |
218,000
-68,500
| -24% | -$3.1M |
|
3071
Frontdoor
FTDR
$5.96B
| $9.13M | ﹤0.01% |
166,946
-99,095
| -37% | -$5.37M |
|
3072
Northern Trust
NTRS
$35B
| $9.11M | ﹤0.01% |
88,906
+87,529
| +6,356% | +$8.95M |
|
3073
PUT
FIVE9
FIVN
$2.47B
| $9.11M | ﹤0.01% |
224,200
+114,300
| +104% | +$4.12M |
|
|
CPRX
3074
DELISTED
Catalyst Pharmaceutical
CPRX
| $9.11M | ﹤0.01% |
436,467
+411,229
| +1,629% | +$8.83M |
|
3075
FirstCash
FCFS
$9.31B
| $9.11M | ﹤0.01% |
87,913
+26,729
| +44% | +$2.88M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.